BioCryst (BCRX) | Stock Overview & Key Data

BioCryst Pharmaceuticals Inc. | Small-cap | Healthcare

$8.57

2.27%

BioCryst vs Zoetis BioCryst vs Haleon Plc - ADR BioCryst vs Ani Pharmaceuticals BioCryst vs BGM BioCryst vs Harrow BioCryst vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

BioCryst Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	BioCryst	Healthcare Sector	S&P 500
1 Week	-0.83%	N/A	N/A
1 Month	-1.64%	N/A	N/A
3 Months	-16.78%	N/A	N/A
6 Months	-9.01%	N/A	N/A
1 Year	3.46%	N/A	N/A
3 Years	-41.23%	N/A	N/A
5 Years	111.08%	N/A	N/A

Stock Range

Today's Range

Low: $8.35 High: $8.62

on August 22, 2025

52 Week Range

Low: $6.02 High: $11.31

on April 10, 2025

on June 4, 2025

All-Time High: $37.25 on March 6, 2000

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $1.8B

EPS i -0.18

P/E Ratio (TTM) i -19.47

Forward P/E i -209.25

P/B Ratio i -4.16

PEG Ratio i 0.15

Div. Yield i N/A

ROE i 18.68%

Beta i 1.099

Debt to Equity i -1.75

Financial Highlights

Profitability

Gross Margin i 98.29%

Operating Margin i 18.23%

Profit Margin i -6.41%

Returns and Earnings

Return on Assets (TTM) i 7.46%

Return on Equity (TTM) i 18.68%

EBITDA i $13.4M

Net Income (TTM) i $-35.7M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i $2.67

Quarterly Revenue Growth (YoY) i 49.40%

Quarterly Earnings Growth (YoY) i 49.41%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
BioCryst BCRX	1.76B Small-cap	-0.83%	-1.64%	-16.78%	-9.01%	7.02%	3.46%	-41.23%	111.08%
Zoetis ZTS	65.30B Large-cap	4.59%	0.82%	-3.89%	-1.51%	-5.23%	-16.11%	-9.09%	-2.69%
Haleon Plc - ADR HLN	43.42B Large-cap	1.13%	2.94%	-11.62%	-2.68%	3.92%	-0.91%	57.46%	32.39%
Ani Pharmaceuticals ANIP	1.90B Small-cap	1.27%	39.34%	54.27%	57.30%	64.39%	47.76%	139.84%	191.55%
BGM BGM	1.55B Small-cap	-0.66%	-29.26%	-39.11%	-23.34%	-15.88%	28.55%	24.30%	-82.81%
Harrow HROW	1.42B Small-cap	-4.62%	2.91%	42.76%	31.81%	4.38%	-10.63%	314.33%	445.14%

Ownership & Short Interest

Insider Ownership i 1.26%

Institutional Ownership i 95.15%

Shares Short i 26M

Short Ratio i 8.05

Short % of Shares Outstanding i 12.38%

Average 10-Day Volume i 3M

Average 90-Day Volume i 3M

BioCryst Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in BioCryst would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of BioCryst, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -0.83%
1 Month: -1.64%
3 Months: -16.78%
1 Year: 3.46%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BCRX's 52-week high and low?

In the last 52 weeks, BioCryst reached a high of $11.31 (on June 4, 2025) and a low of $6.02 (on April 10, 2025).

What is the market cap and P/E ratio for BCRX?

Curious about BioCryst's size and valuation? Its market capitalization stands at 1.76B. When it comes to valuation, the P/E ratio (trailing twelve months) is -19.47, and the forward P/E (looking ahead) is -209.25.

Does BCRX pay dividends? If so, what's the yield?

As for dividends, BioCryst isn't currently offering a significant yield, or that specific data isn't available right now.

Who are BioCryst's main competitors or similar companies to consider before investing?

When looking at BioCryst, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	65.30B	Healthcare	Drug Manufacturers - Specialty & Generic	-16.11%	-9.09%
Haleon Plc - ADR HLN	43.42B	Healthcare	Drug Manufacturers - Specialty & Generic	-0.91%	57.46%
Ani Pharmaceuticals ANIP	1.90B	Healthcare	Drug Manufacturers - Specialty & Generic	47.76%	139.84%
BGM BGM	1.55B	Healthcare	Drug Manufacturers - Specialty & Generic	28.55%	24.30%
Harrow HROW	1.42B	Healthcare	Drug Manufacturers - Specialty & Generic	-10.63%	314.33%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for BioCryst Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)

To get a sense of BioCryst's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.68%, the Debt to Equity ratio from the most recent quarter is -1.75, and its Gross Profit Margin stands at 98.29%.

What is the recent revenue and earnings growth for BCRX?

Looking at BioCryst's growth, its revenue over the trailing twelve months (TTM) was $558M. Compared to the same quarter last year (YoY), quarterly revenue grew by 49.40%, and quarterly earnings saw a YoY growth of 49.41%.

How much of BCRX stock is held by insiders and institutions?

Wondering who owns BioCryst stock? Company insiders (like executives and directors) hold about 1.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.15%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.